0001962783-23-000001.txt : 20230119 0001962783-23-000001.hdr.sgml : 20230119 20230119131706 ACCESSION NUMBER: 0001962783-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 EFFECTIVENESS DATE: 20230119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Thylacine Biotherapeutics Inc CENTRAL INDEX KEY: 0001962783 IRS NUMBER: 861749562 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-471173 FILM NUMBER: 23536831 BUSINESS ADDRESS: STREET 1: 6899 COLLINS AVE STREET 2: SUITE 2604 CITY: MIAMI BEACH STATE: FL ZIP: 33141 BUSINESS PHONE: 6503021392 MAIL ADDRESS: STREET 1: 6899 COLLINS AVE STREET 2: SUITE 2604 CITY: MIAMI BEACH STATE: FL ZIP: 33141 D 1 primary_doc.xml X0708 D LIVE 0001962783 Thylacine Biotherapeutics Inc 6899 COLLINS AVE SUITE 2604 MIAMI BEACH FL FLORIDA 33141 6503021392 DELAWARE None None Corporation true 2021 Daniel Graifman 6899 Collins Ave Suite 2604 Miami Beach FL FLORIDA 33141 Executive Officer Director Robert Graifman 6899 Collins Ave Suite 2604 Miami Beach FL FLORIDA 33141 Director Andrew Fradkin PO Box 727 San Carlos CA CALIFORNIA 94070 Director Biotechnology No Revenues 06b false 2023-01-05 false true true false 5000 Walter Greenblatt & Assoc 129291 None None 325 St Marks Ave Brooklyn NY NEW YORK 11238 CA CALIFORNIA DC DISTRICT OF COLUMBIA FL FLORIDA IL ILLINOIS ME MAINE MD MARYLAND NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA WA WASHINGTON false 1000000 476000 524000 false 13 70000 true 0 sales commission to be paid if offering proceeds are $1 million 100000 true false Thylacine Biotherapeutics Inc Andrew Fradkin Andrew Fradkin Secretary and General Counsel 2023-01-19